FineMark National Bank & Trust’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-308
Closed -$27K 495
2016
Q4
$27K Hold
308
﹤0.01% 761
2016
Q3
$27K Sell
308
-26
-8% -$2.61K ﹤0.01% 747
2016
Q2
$36K Buy
334
+195
+140% +$20.1K ﹤0.01% 684
2016
Q1
$15K Hold
139
﹤0.01% 822
2015
Q4
$12K Hold
139
﹤0.01% 899
2015
Q3
$13K Sell
139
-130
-48% -$13K ﹤0.01% 928
2015
Q2
$29K Buy
+269
New +$27K ﹤0.01% 788

Other funds holding CRI

FineMark National Bank & Trust's CRI Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Carter's (CRI) in Q1 2017, closing a stake of 308 shares — an estimated $27K sold.

FineMark National Bank & Trust first reported a position in CRI in Q2 2015 and held it in 7 quarters. The position peaked at $36K in Q2 2016. 336 funds tracked by Wall St. Rank hold CRI as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Carter's position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 308 Carter's shares in Q1 2017, an estimated $27K.
  • FineMark National Bank & Trust first reported a position in Carter's in Q2 2015 and held it in 7 quarters.
  • FineMark National Bank & Trust's Carter's position peaked at $36K in Q2 2016.
  • 336 funds tracked by Wall St. Rank held Carter's as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.